Rituximab to Treat Neuropathy With Anti-MAG Antibodies

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 27, 2002

Study Completion Date

October 17, 2007

Conditions

Polyneuropathies

Interventions

DRUG

Rituximab

Trial Locations (1)

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors

lead

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

NCT00050245 - Rituximab to Treat Neuropathy With Anti-MAG Antibodies | Biotech Hunter | Biotech Hunter